KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Return on Equity: 2010-2024

Historic Return on Equity for Pacira BioSciences (PCRX) over the last 15 years, with Dec 2024 value amounting to -0.12%.

  • Pacira BioSciences' Return on Equity rose 14.00% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year increase of 14.00%. This contributed to the annual value of -0.12% for FY2024, which is 17.00% down from last year.
  • Pacira BioSciences' Return on Equity amounted to -0.12% in FY2024, which was down 336.82% from 0.05% recorded in FY2023.
  • In the past 5 years, Pacira BioSciences' Return on Equity registered a high of 0.30% during FY2020, and its lowest value of -0.12% during FY2024.
  • Moreover, its 3-year median value for Return on Equity was 0.02% (2022), whereas its average is -0.02%.
  • Its Return on Equity has fluctuated over the past 5 years, first soared by 33bps in 2020, then dropped by 24bps in 2021.
  • Yearly analysis of 5 years shows Pacira BioSciences' Return on Equity stood at 0.30% in 2020, then decreased by 24bps to 0.06% in 2021, then fell by 4bps to 0.02% in 2022, then rose by 3bps to 0.05% in 2023, then dropped by 17bps to -0.12% in 2024.